Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Administered and endogenously released kappa opioids decrease pilocarpine-induced seizures and seizure-induced

S B Bausch1, T M Esteb, G W Terman

  • 1Department of Pharmacology, University of Washington, Seattle, USA.

The Journal of Pharmacology and Experimental Therapeutics
|March 13, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kappa Opioid Receptors in Mesolimbic Terminals Mediate Escalation of Cocaine Consumption.

bioRxiv : the preprint server for biology·2024
Same author

The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.

Brain research·2009
Same author

Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents.

Neuroscience·2009
Same author

Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia.

Neuroscience·2007
Same author

The absence of endogenous beta-endorphin selectively blocks phosphorylation and desensitization of mu opioid receptors following partial sciatic nerve ligation.

Neuroscience·2007
Same author

Potential roles for hyaluronan and CD44 in kainic acid-induced mossy fiber sprouting in organotypic hippocampal slice cultures.

Neuroscience·2006
Same journal

Striatal remodeling in Parkinson disease.

The Journal of pharmacology and experimental therapeutics·2026
Same journal

Loaded and coated: Outer membrane vesicles get a critical boost from a lipopolysaccharide adjuvant payload in a rationally designed anti-Helicobacter pylori nanoparticle.

The Journal of pharmacology and experimental therapeutics·2026
Same journal

Comparative analysis of ligand binding affinities and functional profiles at recombinant human β-adrenergic receptor subtypes 1, 2, and 3.

The Journal of pharmacology and experimental therapeutics·2026
Same journal

Decoding the oncogenic functions and translational potential of Twinfilin-1.

The Journal of pharmacology and experimental therapeutics·2026
Same journal

Antiproliferative effects of HIV integrase strand transfer inhibitors in experimental models for cancer research: A narrative review.

The Journal of pharmacology and experimental therapeutics·2026
Same journal

Modulation of morphine tolerance and dependence by pyrroloquinoline quinone in mice: Insights into mechanistic bridge from N-methyl-D-aspartate receptors-calcium/calmodulin-dependent protein kinase II signaling to oxidative neuroinflammation.

The Journal of pharmacology and experimental therapeutics·2026
See all related articles

Kappa opioids reduce seizure severity and brain damage in epilepsy models. This suggests endogenous kappa opioids may protect against seizures and related histopathology in temporal lobe epilepsy.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Epilepsy Research

Background:

  • Temporal lobe epilepsy is a debilitating neurological disorder.
  • Opioid receptors, particularly kappa opioid receptors, are implicated in neurological functions.
  • Understanding their role in epilepsy is crucial for developing new treatments.

Purpose of the Study:

  • To investigate the neuroprotective effects of kappa opioids in a rat model of temporal lobe epilepsy.
  • To determine if kappa opioid receptor activation influences seizure activity and subsequent brain damage.
  • To explore the role of endogenous kappa opioids in seizure pathology.

Main Methods:

  • Utilized the pilocarpine-induced seizure model in rats.
  • Administered kappa opioid receptor agonists (U50488h, U69593) and antagonists (norbinaltorphimine/nBNI).

Related Experiment Videos

  • Assessed seizure latency, duration, incidence, mossy fiber sprouting, and neuron survival.
  • Performed electrophysiological recordings in the dentate gyrus.

    • Main Results:

    • Kappa opioid agonist U50488h increased seizure latency, decreased seizure duration, reduced mossy fiber sprouting, and enhanced hilar neuron survival.
    • The protective histological effects of U50488h were not blocked by the kappa opioid antagonist nBNI.
    • Treatment with nBNI alone increased seizure incidence, mossy fiber sprouting, and hilar neuron loss.
    • Electrophysiological studies confirmed functional kappa opioid receptors in the ventral dentate gyrus.

    Conclusions:

    • Kappa opioids demonstrate significant anticonvulsant and neuroprotective properties in the pilocarpine model.
    • Endogenous kappa opioids appear to play a protective role in mitigating seizure-induced brain damage.
    • Targeting kappa opioid receptors may offer a therapeutic strategy for temporal lobe epilepsy.